Zimmer Biomet Holdings (ZBH) Reports In-Line Q4 EPS; Guides Q1 Modestly Below the Street

Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.10, in-line with the analyst estimate of $2.10. Revenue for the quarter came in at $2.07 billion versus the consensus estimate of $2.03 billion.

GUIDANCE:

Zimmer Biomet Holdings sees Q1 2018 EPS of $1.84-$1.91, versus the consensus of $2.02. Zimmer Biomet Holdings sees Q1 2018 revenue of $1.955-1.995 billion, versus the consensus of $2.01 billion.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• Broadcom (AVGO) Tops Q2 EPS by 5c, Offers Guidance
• CrowdStrike Holdings Inc. (CRWD) Tops Q1 EPS by 3c, Offers Guidance
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance